Morgan Stanley Pure Tech Health PLC Transaction History
Morgan Stanley
- $1.27 Trillion
- Q2 2024
A detailed history of Morgan Stanley transactions in Pure Tech Health PLC stock. As of the latest transaction made, Morgan Stanley holds 2,827 shares of PRTC stock, worth $55,154. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,827Holding current value
$55,154% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PRTC
# of Institutions
7Shares Held
322KCall Options Held
0Put Options Held
0-
Birch Hill Investment Advisors LLC302KShares$5.89 Million0.37% of portfolio
-
Pentwater Capital Management LP Naples, FL16.2KShares$315,9250.01% of portfolio
-
Adar1 Capital Management, LLC Austin, TX700Shares$13,6570.0% of portfolio
-
Ubs Group Ag351Shares$6,8480.0% of portfolio
-
Tower Research Capital LLC (Trc) New York, NY73Shares$1,4240.0% of portfolio
About PureTech Health plc
- Ticker PRTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,888,500
- Market Cap $544M
- Description
- PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company offers KarXT targeting muscarinic acetylcholi...